Overweight and obesity may lead to under-diagnosis of airflow limitation: Findings from the Copenhagen City Heart Study

COPD: Journal of Chronic Obstructive Pulmonary Disease

Volumn 12, Issue 1, 2015, Pages 5-13

  C¸olak, Yunus ^a,b,c   Marott, Jacob Louis ^c   Vestbo, Jørgen ^a,d   Lange, Peter ^b,c,e  

^a GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c FREDERIKSBERG HOSPITAL   (Denmark)

^d UNIVERSITY OF MANCHESTER   (United Kingdom)

^e HVIDOVRE HOSPITAL   (Denmark)

Author keywords

Airflow limitation; Airway obstruction; Body mass index; Chronic obstructive pulmonary disease; Diagnosis; Epidemiology; Lower limit of normal; Lung function; Obesity; Spirometry

Indexed keywords

ABDOMINAL HEIGHT; ADULT; AGE; ANTHROPOMETRIC PARAMETERS; ARTICLE; BODY MASS; BODY WEIGHT; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL FEATURE; DIAGNOSTIC ERROR; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE ASSOCIATION; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OBESITY; PREDICTIVE VALUE; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; SEX DIFFERENCE; SEX RATIO; SMOKING; TOBACCO CONSUMPTION; WAIST CIRCUMFERENCE; WAIST HIP RATIO; WEIGHT, MASS AND SIZE; AGED; COMPLICATION; CROSS-SECTIONAL STUDY; DENMARK; EVALUATION STUDY; OVERWEIGHT; PATHOPHYSIOLOGY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTOR; STATISTICAL MODEL; VITAL CAPACITY;

ADULT; AGED; BODY MASS INDEX; CROSS-SECTIONAL STUDIES; DENMARK; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; OBESITY; OVERWEIGHT; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTORS; VITAL CAPACITY;

EID: 84923086497     PISSN: 15412555     EISSN: 15412563     Source Type: Journal    
DOI: 10.3109/15412555.2014.933955     Document Type: Article

References (49)

1. Mannino DM, Braman S. THE epidemiology and economics of chronic obstructive pulmonary disease. Proc Am Th orac Soc 2007 Oct 1; 4(7):502-506.
2. Fontaine KR, Redden DT, Wang C, Westfall AO, Allison DB. Years of life lost due to obesity. JAMA 2003 Jan 8; 289(2):187-193.
3. Lavie CJ, Milani RV, Ventura HO. Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss. J Am Coll Cardiol 2009 May 26; 53(21):1925-1932.
4. Murray CJ, Lopez AD. Mortality by cause for eight regions of the world: Global Burden of Disease Study. Lancet 1997 May 3; 349(9061):1269-1276.
5. Finucane MM, Stevens GA, Cowan MJ, Danaei G, Lin JK, Paciorek CJ, et al. National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9.1 million participants. Lancet 2011 Feb 12; 377(9765):557-567.
6. Franssen FM, O'Donnell DE, Goossens GH, Blaak EE, Schols AM. Obesity and the lung: 5. Obesity and COPD. Thorax 2008 Dec; 63(12):1110-1117.
7. Cecere LM, Littman AJ, Slatore CG, Udris EM, Bryson CL, Boyko EJ, et al. Obesity and COPD: associated symptoms, health-related quality of life, and medication use. COPD 2011 Aug; 8(4):275-184.
8. Lazarus R, Sparrow D, Weiss ST. Effects of obesity and fat distribution on ventilatory function: the normative aging study. Chest 1997 Apr; 111(4):891-898.
9. Ray CS, Sue DY, Bray G, Hansen JE, Wasserman K. Effects of obesity on respiratory function. Am Rev Respir Dis 1983 Sep; 128(3):501-506.
10. O'Donnell DE, Deesomchok A, Lam YM, Guenette JA, Amornputtisathaporn N, Forkert L, et al. Effects of BMI on static lung volumes in patients with airway obstruction. Chest 2011 Aug; 140(2):461-468.
11. Ochs-Balcom HM, Grant BJ, Muti P, Sempos CT, Freudenheim JL, Trevisan M, et al. Pulmonary function and abdominal adiposity in the general population. Chest 2006 Apr; 129(4):853-862.
12. van den Bemt L, van Wayenburg CA, Smeele IJ, Schermer TR. Obesity in patients with COPD, an undervalued problem? Thorax 2009 Jul; 64(7):640-641.
13. Appleyard M ed. THE Copenhagen City Heart Study. Østerbroundersogelsen. A book of tables with data from the first examination (1976-78) and a five year follow-up (1981-83). THE Copenhagen City Heart Study Group. Scand J Soc Med 1989; 41 (Suppl.):1-160.
14. Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser 2000; 894:i-253.
15. Bhatt SP, Sieren JC, Dransfi eld MT, Washko GR, Newell JD, Jr., Stinson DS, et al. Comparison of spirometric thresholds in diagnosing smoking-related airflow obstruction. Thorax 2014 May; 69(5):410-415.
16. C¸olak Y, Løkke A, Marott JL, Lange P, Vestbo J. Impact of diagnostic criteria on the prevalence of COPD. Clin Respir J 2013 Jul; 7(3):297-303.
17. Mohamed Hoesein FA, Zanen P, Lammers JW. Lower limit of normal or FEV1/FVC < 0.70 in diagnosing COPD: an evidence-based review. Respir Med 2011 Jun;105(6):907-15.
18. van Dijk WD, Gupta N, Tan WC, Bourbeau J. Clinical relevance of diagnosing COPD by fi xed ratio or lower limit of normal: a systematic review. COPD 2014 Feb; 11(1):113-120.
19. O'Donnell DE, Ciavaglia CE, Neder JA. When obesity and chronic obstructive pulmonary disease collide. Physiological and clinical consequences. Ann Am Th orac Soc 2014 May; 11(4):635-644.
20. Bottai M, Pistelli F, Di PF, Carrozzi L, Baldacci S, Matteelli G, et al. Longitudinal changes of body mass index, spirometry and diffusion in a general population. Eur Respir J 2002 Sep; 20(3):665-673.
21. Tchernof A, Despres JP. Pathophysiology of human visceral obesity: an update. Physiol Rev 2013 Jan; 93(1):359-404.
22. Canoy D, Luben R, Welch A, Bingham S, Wareham N, Day N, et al. Abdominal obesity and respiratory function in men and women in the EPIC-Norfolk Study, United Kingdom. Am J Epidemiol 2004 Jun 15; 159(12):1140-1149.
23. Chen R, Tunstall-Pedoe H, Bolton-Smith C, Hannah MK, Morrison C. Association of dietary antioxidants and waist circumference with pulmonary function and airway obstruction. Am J Epidemiol 2001 Jan 15; 153(2):157-163.
24. Collins LC, Hoberty PD, Walker JF, Fletcher EC, Peiris AN. THE effect of body fat distribution on pulmonary function tests. Chest 1995 May; 107(5):1298-1302.
25. Harik-Khan RI, Wise RA, Fleg JL. THE effect of gender on the relationship between body fat distribution and lung function. J Clin Epidemiol 2001 Apr; 54(4):399-406.
26. Lazarus R, Gore CJ, Booth M, Owen N. Effects of body composition and fat distribution on ventilatory function in adults. Am J Clin Nutr 1998 Jul; 68(1):35-41.
27. Leone N, Courbon D, Th omas F, Bean K, Jego B, Leynaert B, et al. Lung function impairment and metabolic syndrome: the critical role of abdominal obesity. Am J Respir Crit Care Med 2009 Mar 15; 179(6):509-516.
28. Carey IM, Cook DG, Strachan DP. THE effects of adiposity and weight change on forced expiratory volume decline in a longitudinal study of adults. Int J Obes Relat Metab Disord 1999 Sep; 23(9):979-985.
29. Chen Y, Horne SL, Dosman JA. Body weight and weight gain related to pulmonary function decline in adults: a six year follow up study. Thorax 1993 Apr; 48(4):375-380.
30. Chinn DJ, Cotes JE, Reed JW. Longitudinal effects of change in body mass on measurements of ventilatory capacity. Thorax 1996 Jul; 51(7):699-704.
31. Chinn S, Jarvis D, Melotti R, Luczynska C, Ackermann- Liebrich U, Anto JM, et al. Smoking cessation, lung function, and weight gain: a follow-up study. Lancet 2005 May 7; 365(9471):1629-1635.
32. Wang ML, McCabe L, Hankinson JL, Shamssain MH, Gunel E, Lapp NL, et al. Longitudinal and cross-sectional analyses of lung function in steelworkers. Am J Respir Crit Care Med 1996 Jun; 153(6 Pt 1):1907-1913.
33. Wise RA, Enright PL, Connett JE, Anthonisen NR, Kanner RE, Lindgren P, et al. Effect of weight gain on pulmonary function after smoking cessation in the Lung Health Study. Am J Respir Crit Care Med 1998 Mar; 157(3 Pt 1):866-872.
34. Celli BR, Th omas NE, Anderson JA, Ferguson GT, Jenkins CR, Jones PW, et al. Effect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease: results from the TORCH study. Am J Respir Crit Care Med 2008 Aug 15; 178(4):332-338.
35. Harik-Khan RI, Fleg JL, Wise RA. Body mass index and the risk of COPD. Chest 2002 Feb; 121(2):370-376.
36. Chailleux E, Fauroux B, Binet F, Dautzenberg B, Polu JM. Predictors of survival in patients receiving domiciliary oxygen therapy or mechanical ventilation. A 10-year analysis of ANTADIR Observatory. Chest 1996 Mar; 109(3):741-749.
37. Chailleux E, Laaban JP, Veale D. Prognostic value of nutritional depletion in patients with COPD treated by long-term oxygen therapy: data from the ANTADIR observatory. Chest 2003 May; 123(5):1460-1466.
38. Gray-Donald K, Gibbons L, Shapiro SH, Macklem PT, Martin JG. Nutritional status and mortality in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1996 Mar; 153(3):961-966.
39. Landbo C, Prescott E, Lange P, Vestbo J, Almdal TP. Prognostic value of nutritional status in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999 Dec; 160(6):1856-1861.
40. Lindsted KD, Singh PN. Body mass and 26 y risk of mortality among men who never smoked: a re-analysis among men from the Adventist Mortality Study. Int J Obes Relat Metab Disord 1998 Jun; 22(6):544-548.
41. Schols AM, Slangen J, Volovics L, Wouters EF. Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998 Jun; 157(6 Pt 1):1791-1797.
42. Sharp DS, Burchfi el CM, Curb JD, Rodriguez BL, Enright PL. THE synergy of low lung function and low body mass index predicting all-cause mortality among older Japanese-American men. J Am Geriatr Soc 1997 Dec; 45(12):1464-1471.
43. Singh PN, Lindsted KD. Body mass and 26-year risk of mortality from specifi c diseases among women who never smoked. Epidemiology 1998 May; 9(3):246-254.
44. Ali Z, Ulrik CS. Obesity and asthma: a coincidence or a causal relationship? A systematic review. Respir Med 2013 Sep; 107(9):1287-1300.
45. Ford ES. THE epidemiology of obesity and asthma. J Allergy Clin Immunol 2005 May; 115(5):897-909.
46. Schachter LM, Salome CM, Peat JK, Woolcock AJ. Obesity is a risk for asthma and wheeze but not airway hyperresponsiveness. Thorax 2001 Jan; 56(1):4-8.
47. Hakala K, Stenius-Aarniala B, Sovijarvi A. Effects of weight loss on peak flow variability, airways obstruction, and lung volumes in obese patients with asthma. Chest 2000 Nov; 118(5):1315-1321.
48. Aaron SD, Fergusson D, Dent R, Chen Y, Vandemheen KL, Dales RE. Effect of weight reduction on respiratory function and airway reactivity in obese women. Chest 2004 Jun; 125(6):2046-2052.
49. Johannessen A, Omenaas ER, Bakke PS, Gulsvik A. Implications of reversibility testing on prevalence and risk factors for chronic obstructive pulmonary disease: a community study. Thorax 2005 Oct; 60(10):842-847.